5-HT1A receptors, gene repression, and depression: guilt by association

Paul R Albert1, Sylvie Lemonde

  • 1Ottawa Health Research Institute, Neuroscience University of Ottawa, Ottawa, Canada.

Insights

Altered regulation of serotonin 5-HT1A autoreceptors is linked to depression and anxiety. A specific gene polymorphism may increase susceptibility to mental illness by affecting this regulation.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Molecular Biology

Background:

  • The serotonin system is crucial for mood regulation and is implicated in major depression and suicide.
  • Somatodendritic 5-HT1A autoreceptors negatively regulate the serotonin system.
  • Desensitization of these autoreceptors contributes to the delayed onset of antidepressant effects.

Purpose of the Study:

  • To explore the role of altered 5-HT1A receptor gene transcriptional regulation in mental disorders.
  • To investigate the link between 5-HT1A receptor gene regulation and predisposition to depression, anxiety, and suicide.

Main Methods:

  • Review of existing evidence on 5-HT1A receptor regulation and its association with mental illness.
  • Examination of the impact of specific 5-HT1A gene polymorphisms on receptor function and repression.
  • Analysis of the role of transcriptional repressors (REST/NRSF, Freud-1, NUDR/Deaf-1, Hes5) on the 5-HT1A receptor gene.

Main Results:

  • Alterations in 5-HT1A receptor levels are observed in depression and suicide.
  • Gene knockout of the 5-HT1A receptor leads to an anxiety phenotype.
  • A functional 5-HT1A polymorphism (C(-1019)G) affects autoreceptor repression by NUDR, linking it to major depression, suicide, and panic disorder.

Conclusions:

  • Abnormal transcriptional regulation of the 5-HT1A receptor gene may underlie predisposition to mental illness.
  • Altered 5-HT1A receptor transcription impacts the serotonin system and brain areas involved in mood regulation, potentially leading to depression.

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...